Serina Therapeutics is a recently founded biopharmaceutical company that develops novel polymeric drug delivery systems. Serina has assembled an internationally renowned scientific and business team to create novel technologies in the areas of long-acting pharmaceuticals, drug solubilization, drug absorption and metabolism, and cell targeting.
Serina has used its patented polymer platforms to synthesize new polymer-drug constructs for feasibility studies that include product characterization, formulation development and preclinical biology.
Serina has developed a proprietary program that includes polymer-drug conjugates of small molecules, peptides, proteins, antibodies and nucleic acids. Serina also works with biopharmaceutical companies to enhance old products through life-cycle management, and new products through strategic research and development partnerships.
Mission
To develop biocompatible pharmaceutical delivery systems which improve the safety and efficacy of new and existing medicines.
- Specific drug delivery platforms for specific clinical indications
- Strong and cordial research and business partnerships
- Intellectual property creation through good science
